Accelerate Diagnostics Inc (AXDX)

19.85
0.26 1.30
NASDAQ : Health Care
Prev Close 19.59
Open 19.69
Day Low/High 19.34 / 19.91
52 Wk Low/High 10.29 / 29.43
Volume 58.45K
Avg Volume 288.90K
Exchange NASDAQ
Shares Outstanding 51.22M
Market Cap 1.01B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

AXDX: Insiders vs. Shorts

AXDX: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and Accelerate Diagnostics Inc is one of the most shorted stocks of the Russell 3000, based on 21.25 "days to cover" versus the median component at 6.29. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Accelerate Diagnostics (AXDX) Is Weak On High Volume Today

Accelerate Diagnostics (AXDX) Is Weak On High Volume Today

Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a weak on high relative volume candidate

Noteworthy Wednesday Option Activity: AXDX, MTZ, VHC

Noteworthy Wednesday Option Activity: AXDX, MTZ, VHC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Accelerate Diagnostics Inc , where a total volume of 2,533 contracts has been traded thus far today, a contract volume which is representative of approximately 253,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 118.7% of AXDX's average daily trading volume over the past month, of 213,440 shares.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Commit To Buy Accelerate Diagnostics At $10, Earn 19.8% Annualized Using Options

Commit To Buy Accelerate Diagnostics At $10, Earn 19.8% Annualized Using Options

Investors eyeing a purchase of Accelerate Diagnostics Inc shares, but tentative about paying the going market price of $12.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $10 strike, which has a bid at the time of this writing of $1.10.

Accelerate Diagnostics (AXDX) Strong On High Relative Volume Today

Accelerate Diagnostics (AXDX) Strong On High Relative Volume Today

Trade-Ideas LLC identified Accelerate Diagnostics (AXDX) as a strong on high relative volume candidate

Commit To Purchase Accelerate Diagnostics At $10, Earn 21% Annualized Using Options

Commit To Purchase Accelerate Diagnostics At $10, Earn 21% Annualized Using Options

Investors eyeing a purchase of Accelerate Diagnostics Inc shares, but cautious about paying the going market price of $13.83/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May put at the $10 strike, which has a bid at the time of this writing of 65 cents.

Accelerate Diagnostics is Now Oversold (AXDX)

Accelerate Diagnostics is Now Oversold (AXDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

New 52-Week Low Could Prompt More Insider Buying At AXDX

New 52-Week Low Could Prompt More Insider Buying At AXDX

In trading on Wednesday, shares of Accelerate Diagnostics Inc touched a new 52-week low of $13.78/share. That's a $17.51 share price drop, or -55.96% decline from the 52-week high of $31.29 set back on 07/23/2015.

Commit To Purchase Accelerate Diagnostics At $12.50, Earn 14.2% Annualized Using Options

Commit To Purchase Accelerate Diagnostics At $12.50, Earn 14.2% Annualized Using Options

Investors eyeing a purchase of Accelerate Diagnostics Inc stock, but cautious about paying the going market price of $18.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2016 put at the $12.50 strike, which has a bid at the time of this writing of 80 cents.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Insider Trading Alert - CTIC, CRM And AXDX Traded By Insiders

Insider Trading Alert - CTIC, CRM And AXDX Traded By Insiders

Stocks with insider trader activity include CTIC, CRM and AXDX

Accelerate Diagnostics Enters Oversold Territory (AXDX)

Accelerate Diagnostics Enters Oversold Territory (AXDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Accelerate Diagnostics At $15, Earn 31.3% Annualized Using Options

Commit To Purchase Accelerate Diagnostics At $15, Earn 31.3% Annualized Using Options

Investors considering a purchase of Accelerate Diagnostics Inc stock, but cautious about paying the going market price of $17.36/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2016 put at the $15 strike, which has a bid at the time of this writing of $2.10.

Oversold Conditions For Accelerate Diagnostics (AXDX)

Oversold Conditions For Accelerate Diagnostics (AXDX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.